Related Stories GLP-1 weight-loss drugs may also reduce binge eating Semaglutide fuels rapid growth in US GLP-1RA use as payments rise Study links GLP-1 treatment to fewer alcohol drinking days In comparison to composite control, GLP-1RA use exhibited a decreased risk of 34 outcomes, including pneumonia, respiratory failure, alcohol use disorders, COPD, and suicidal ideation, and an increased risk of 17 outcomes, including abdominal pain, GERD, nephrolithiasis, and sleep disturbances
Dual antiplatelet therapy may be considered after an acute coronary syndrome
Heres what we recommend: Eat for Longevity, Not Just Satiety: While GLP-1s reduce hunger, its vital to prioritize protein intake
Controversy surrounding "Sick of the System" began nearly two weeks before the big game